Skip to content
10-Q

Quarterly Report

FUSE MEDICAL, INC. FZMD

0001564590-22-019837

← back to feed
Filed
May 12, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 10, 2022 72.9M sh
Capex Q1 2022 · Mar 31, 2022 $138.84K
Cash And Equivalents Q1 2022 · Mar 31, 2022 $522.49K
Cash And Equivalents Q1 2022 · Dec 31, 2021 $553.19K
Current Liabilities Q1 2022 · Mar 31, 2022 $9.76M
Current Liabilities Q1 2022 · Dec 31, 2021 $9.94M
Total Liabilities Q1 2022 · Mar 31, 2022 $21.55M
Total Liabilities Q1 2022 · Dec 31, 2021 $21.74M
Current Assets Q1 2022 · Mar 31, 2022 $12.05M
Current Assets Q1 2022 · Dec 31, 2021 $12.82M
Total Assets Q1 2022 · Mar 31, 2022 $17.77M
Total Assets Q1 2022 · Dec 31, 2021 $18.3M
Operating Cash Flow Q1 2022 · Mar 31, 2021 $55.34K
Stockholders Equity Q1 2022 · Mar 31, 2021 −$2.45M
Stockholders Equity Q1 2022 · Dec 31, 2020 −$2.11M
Sga Expense Q1 2022 · Mar 31, 2021 $1.44M
Net Income Q1 2022 · Mar 31, 2021 −$453.32K
Operating Income Q1 2022 · Mar 31, 2021 −$429.96K
Gross Profit Q1 2022 · Mar 31, 2021 $2.59M
Cost Of Revenue Q1 2022 · Mar 31, 2021 $1.85M
Revenue Q1 2022 · Mar 31, 2021 $4.44M